Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Authorities should focus on India's real health problem: fake and substandard medicines.
ABSTRACT
Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety. According to the World Health Organization, some poor quality drugs are deliberately and fraudulently mislabeled with respect to identity or source while...
Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety.
AEI's Danielle Pletka, vice president of foreign and defense policy studies explains in a new post why these negotiations are destined to fail and a new report by AEI Iran expert Ali Alfoneh on Iranian Brigadier General Gholamreza Baghbani, the current chief of Iran's Islamic Revolutionary Guards Corps Quds Force (IRGC QF) office in Zahedan, and a narcotics trafficker.
Without profound changes in the scientific and regulatory environment, things will remain very tough for the agile disruptor -- relatively good news for established giants, presumably less good news for patients and for progress.
Alice Ndlovu has tuberculosis but, relatively speaking, she is one of the lucky ones. Hers is a strain that responds to the best medicines available, which also happen to be the cheapest. At 28, this single mom knows that without treatment she would likely die, leaving her child to face...
Here is another good news/bad news column about the 112th Congress.
Background
About a third of the world’s population, concentrated in poorer regions of the world, may be infected with TB, which generally lies dormant until the carrier’s immunity is impaired by another disease (often HIV infection). Without treatment, about half of the patients with active TB will die. According to WHO...





